Ultragreen Ai Ltd
Company Profile
Business description
Ultragreen Ai Ltd operates in the fluorescence-guided surgery (FGS) sector and develops vertical AI tools that use data-driven fluorescence imaging solutions for surgical applications. It provides a fluorescence imaging ecosystem designed to support surgeons with real-time perfusion data and visualization capabilities. The company is organised into business units based on its products and services and operates in (a) the Diagnostic Green (DxG) - Americas segment; (b) the DxG - Rest of the World segment; and (c) the UltraLinQ segment. The company generates the majority of its revenue from the DxG - Americas segment, which focuses on the sales of ICG vials and related pharmaceutical products.
Contact
463 MacPherson Road
No. 06-00, M463
Singapore368181
SGPT: +65 98172903
Sector
Healthcare
Stock type
Defensive
Industry
Health Information Services
Fiscal Year End
31 December 2026
Employees
101
Stocks News & Analysis
stocks
Jet fuel price spike weighing on Australian airline profits
stocks
US utilities stocks keep rallying as investors bet on power demand growth
stocks
What did Morningstar subscribers buy and sell during March?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,180.00 | 30.20 | -0.33% |
| CAC 40 | 8,327.86 | 91.88 | 1.12% |
| DAX 40 | 24,044.22 | 301.78 | 1.27% |
| Dow JONES (US) | 48,535.99 | 317.74 | 0.66% |
| FTSE 100 | 10,609.06 | 26.10 | 0.25% |
| HKSE | 26,076.95 | 204.63 | 0.79% |
| NASDAQ | 23,639.08 | 455.35 | 1.96% |
| Nikkei 225 | 58,162.84 | 285.45 | 0.49% |
| NZX 50 Index | 13,084.30 | 67.04 | 0.52% |
| S&P 500 | 6,967.38 | 81.14 | 1.18% |
| S&P/ASX 200 | 8,977.00 | 34.40 | -0.38% |
| SSE Composite Index | 4,036.91 | 10.28 | 0.26% |